Administrative Core
行政核心
基本信息
- 批准号:8499751
- 负责人:
- 金额:$ 10.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdministratorAdvisory CommitteesAdvocateBioinformaticsBiometryCancer CenterCancer Center Support GrantClinicalClinical TrialsCommittee MembershipCommunicationConsultationsDataDevelopmentEarly DiagnosisEducationElectronicsEligibility DeterminationEnsureLaboratoriesMinorityMonitorNational Cancer InstituteOrganOutcomePathologyPatientsPoliciesPreparationPrincipal InvestigatorProgress ReportsPublicationsRegulationReportingReproduction sporesResearchResearch ActivityResearch InfrastructureResearch PersonnelSiteTissuesTranslational ResearchUniversity of Texas M D Anderson Cancer CenterWomanWorkcareer developmentdata managementdesignindexinglecturesleukemiameetingsprogramsquality assurancesuccesssymposiumweb site
项目摘要
The Administrative Core, directed by Dr. Hagop Kantarjian, provides critical centralized administrative
support to ensure the success of the entire SPORE. The specific objectives of the Administrative Core are:
Oversee all SPORE activities, in particular the research activities
Promote integration and communication between the SPORE, the Leukemia Program, and the Cancer
Center Support (Core) Grant
Ensure compliance with institutional, governmental, and NCI regulations
Assume responsibility for coinmunications and consultations with the NCI project officer and other NCI
staff to ensure timely preparation and submission of reports and publications
Oversee the fiscal and budgetary activities of the SPORE
Coordinate data control quality assurance issues in conjunction with the Internal Scientific Advisory
Committee and the Biostatistics and Data Management Core (Core C)
Coordinate activities associated with clinical trials, e.g., designs, approval by regulatory bodies,
implementation, and eligibility and assignment of patients to different studies
Provide oversight and support for the Biostatistics and Data Management Core (Core C) and the
Pathology and Tissue Core (Core B)
Coordinate meetings of the [Executive Committee, the Internal and External Scientific Advisory
Committees, monthly investigator meetings, quarterly research meetings, lectures, and symposia
Administer the Developmental Research Program and the Career Development Program
Administer the activities of the Patient Advocates
Ensure compliance with and improvement of policies for recruitment of women and minorities
Coordinate with other Leukemia SPORE programs and investigators, and other organ-site SPORE
programs, to promote communications and integration, through sponsoring a yearly SPORE conference,
and distribute materials, electronic communications and progress reports
Organize seminars to bring to M. D. Anderson consultants and speakers; sponsor a yearly conference on
Translational Research in Leukemia
RELEVANCE (See InstrLctions):
The Administrative Core provides the support and infrastructure for research and financial oversight; clear
and open communications among all SPORE investigators, patient advocates, and developmental
awardees; and regulatory monitoring to optimize the successful outcome of the translational research in
leukemia.
由 Hagop Kantarjian 博士领导的行政核心提供了关键的集中管理
支持以确保整个 SPORE 的成功。行政核心的具体目标是:
监督所有 SPORE 活动,特别是研究活动
促进 SPORE、白血病项目和癌症之间的整合和沟通
中心支持(核心)补助金
确保遵守机构、政府和 NCI 法规
负责与NCI项目官员和其他NCI的沟通和协商
工作人员确保及时准备和提交报告和出版物
监督 SPORE 的财政和预算活动
与内部科学咨询协调数据控制质量保证问题
委员会以及生物统计和数据管理核心(核心 C)
协调与临床试验相关的活动,例如设计、监管机构的批准、
实施、患者参加不同研究的资格和分配
为生物统计和数据管理核心(核心 C)和
病理学和组织核心(核心 B)
协调[执行委员会、内部和外部科学咨询
委员会、每月研究者会议、季度研究会议、讲座和研讨会
管理发展研究计划和职业发展计划
管理患者权益倡导者的活动
确保遵守并改进招聘妇女和少数民族的政策
与其他白血病 SPORE 项目和研究人员以及其他器官部位 SPORE 协调
计划,通过赞助一年一度的 SPORE 会议来促进沟通和融合,
并分发材料、电子通讯和进度报告
组织研讨会,为 M.D. Anderson 聘请顾问和演讲者;赞助年度会议
白血病的转化研究
相关性(参见说明):
行政核心为研究和财务监督提供支持和基础设施;清除
所有 SPORE 研究人员、患者倡导者和发展人员之间进行开放式沟通
获奖者;和监管监督,以优化转化研究的成功结果
白血病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAGOP KANTARJIAN其他文献
HAGOP KANTARJIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAGOP KANTARJIAN', 18)}}的其他基金
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)
骨髓增生异常综合征 (MDS) 的生物学和治疗新方法
- 批准号:
7628028 - 财政年份:2005
- 资助金额:
$ 10.25万 - 项目类别:
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)
骨髓增生异常综合征 (MDS) 的生物学和治疗新方法
- 批准号:
7437345 - 财政年份:2005
- 资助金额:
$ 10.25万 - 项目类别:
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
SPORE 德克萨斯大学 M.D. 安德森癌症中心 SPORE-白血病
- 批准号:
8734325 - 财政年份:2003
- 资助金额:
$ 10.25万 - 项目类别:
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
SPORE 德克萨斯大学 M.D. 安德森癌症中心 SPORE-白血病
- 批准号:
9123547 - 财政年份:2003
- 资助金额:
$ 10.25万 - 项目类别:
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
SPORE 德克萨斯大学 M.D. 安德森癌症中心 SPORE-白血病
- 批准号:
8472926 - 财政年份:2003
- 资助金额:
$ 10.25万 - 项目类别:
相似海外基金
Admin: Mechanical determinants of organ-selective metastatic colonization, dormancy and outgrowth
管理员:器官选择性转移定植、休眠和生长的机械决定因素
- 批准号:
10688245 - 财政年份:2021
- 资助金额:
$ 10.25万 - 项目类别:
Improving breast cancer risk assessment and prevention in Asian American women
改善亚裔美国女性的乳腺癌风险评估和预防
- 批准号:
10879960 - 财政年份:2021
- 资助金额:
$ 10.25万 - 项目类别:
Admin: Mechanical determinants of organ-selective metastatic colonization, dormancy and outgrowth
管理员:器官选择性转移定植、休眠和生长的机械决定因素
- 批准号:
10490282 - 财政年份:2021
- 资助金额:
$ 10.25万 - 项目类别:
1/2 CSUF/UCI-CFCCC Cancer Health Disparities Research Program (CHERP)
1/2 CSUF/UCI-CFCCC 癌症健康差异研究计划 (CHERP)
- 批准号:
10492739 - 财政年份:2021
- 资助金额:
$ 10.25万 - 项目类别: